To improve the neurologic outcomes for infants with brain injury, neonatal providers are increasingly implementing neurocritical care approaches into clinical practice. Term infants with brain injury have been principal beneficiaries of neurologically-integrated care models to date, as evidenced by the widespread adoption of therapeutic hypothermia protocols for hypoxic-ischemic encephalopathy. Innovative therapeutic and diagnostic support for very low birth weight infants with brain injury has lagged behind. Given that concern for significant future neurodevelopmental impairment can lead to decisions to withdraw life supportive care at any gestational age, providing families with accurate prognostic information is essential for all infants. Current variable application of multidisciplinary neurocritical care approaches to infants at different gestational ages may be ethically problematic and reflect distinct perceptions of brain injury for infants born extremely premature.
INTRODUCTION
Neurocritical care is rapidly developing as a distinct clinical entity to improve outcomes of adult and pediatric patients with neurologic injuries. 1, 2 Recognizing the significant burden of neurologic impairment in survivors of neonatal critical care, neonatologists are increasingly aligning with neurologists, neuroradiologists and developmental specialists to form interdisciplinary neonatal neurocritical care services with the goal of improving developmental outcomes for neurologically at-risk infants. [3] [4] [5] These efforts have been augmented by the emergence of dedicated neonatal neurologists 4 and technological advancements in ultrasonography and magnetic resonance imaging (MRI), which have improved neurologic injury detection and characterization, enhancing the abilities of neonatal providers to prognosticate about future neurodevelopmental disability for parents. 6 Newer bedside neurodiagnostic technologies such as continuous amplitudeintegrated electroencephalography (aEEG) and video EEG have likewise provided neonatal clinicians improved seizure-detection tools, allowing for more expedient interventions that could impact neurodevelopmental outcomes. 6, 7 Term infants with hypoxic-ischemic encephalopathy (HIE) have been a principal focus of neurologically integrated care approaches to date. 4, 5 HIE is a common cause of death and neurologic morbidity for term infants 8 and contributes to significant worldwide mortality. 9 HIE complicates 1.5/1000 full-term births 10 and conservatively about 6000 infants are diagnosed with HIE in the US each year. 11 Widespread adoption of therapeutic hypothermia protocols, developed from clinical trials showing benefit for systematic treatment of these infants, has reduced neurologic morbidity and improved survival in this population. 12 Another group of neurologically at-risk infants, those born extremely premature (prior to 28 weeks gestation) and/or with very low birth weights (VLBW; birth weights less than 1500 g), have been included less routinely in neurologically integrated care approaches. 4 Frequent clinical complications in this population, including significant intraventricular hemorrhages (IVH), sepsis, necrotizing enterocolitis and chronic lung disease, place these infants at risk for substantial neurodevelopment impairments. IVH alone complicates 15% of neonatal admissions with VLBW 13 impacting roughly 9000 VLBW infants in the US yearly. 14 Concern for neurodevelopmental impairment (NDI) in term and extremely preterm infants with brain injury can lead neonatal providers to offer parents the option to withdraw life-sustaining care. 15 Neurologic injury severity, though, is frequently uncertain in both populations, especially in the first few days after diagnosis. 16, 17 Therefore, variable approaches to neurodiagnostic evaluation among different populations of neurologically at-risk infants, including the use of MRI versus ultrasonography for neurodevelopmental predictions and to support decisions to withdraw care, 18 may be problematic. The objective of this paper is to more fully describe current approaches to medical decisionmaking in these contexts, arguing for more uniformity in neurodiagnostic approaches and the adoption of neurologically integrated care approaches that are equitably distributed to all infants.
Clinical care approaches for neurologically at-risk term infants Case: Today is day of life 4 for Clara, born at 40 weeks gestation after a delivery complicated by a placental abruption. She required substantial resuscitation at birth and her Apgar scores were 1 at 1 min and 4 at 5 min. Following intubation, her care transferred to a level IV neonatal intensive care unit at a university hospital where she was found to have profound metabolic acidosis. On neurologic examination, she exhibited no volitional responses to external stimuli, flaccid muscle tone, and absence of deep tendon and primitive reflexes. A head ultrasound (HUS) showed substantial cerebral edema and therapeutic hypothermia was initiated. After a 3-day period of cooling, Clara was rewarmed but remains ventilatordependent and minimally responsive. Her aEEG shows significant discontinuity with intermittent burst suppression. Today, a brain MRI is planned. During teaching rounds, the pediatric resident asks if anyone has discussed withdrawal of life support with the family.
Infants with HIE have been historically classified as either having mild, moderate or severe encephalopathy through Sarnat staging, which incorporates neurologic examination and EEG findings. 19 A modified system, based upon physical examination alone, is more commonly used in current practice. 20 As in Clara's case, principal features of infants with severe encephalopathy include nonresponsiveness with respiratory failure, flaccid muscle tone and absent reflexes. Infants with more moderate encephalopathy typically exhibit a depressed mental state, hypotonia, and weak and/or exaggerated reflexes. Assessments of encephalopathy based solely on physical examinations, however, lack precision and objectivity. 12, 21 This has led to increasing provider utilization of continuous aEEG monitoring to help determine neonatal encephalopathy severity and better identify infants likely to have persistent encephalopathy. [21] [22] [23] For infants undergoing therapeutic hypothermia, aEEG abnormalities that persist after 48 h of life are predictive of NDIs and are sometimes incorporated into decisions to withdraw life-sustaining care. 23, 24 Adverse outcomes of HIE include death, cerebral palsy and cognitive impairments in about 33% of moderate HIE cases and almost 100% of cases with severe HIE. 25 Many of the deaths in infants with HIE follow decisions to withdraw life support. 8 Centers report withdrawal rates around 25% for the population of infants with moderate or severe HIE. 3, 26 Early in hospitalization, when brain swelling is the greatest and spontaneous breathing is diminished, a 'window of opportunity' often exists in mechanically ventilated infants with HIE to withdraw life-supportive care. 27 However, given the outcome variability in this population, early ventilator withdrawals have been discouraged to allow for more clinical certainty regarding the likelihood of NDI, usually more definitive by a week or two of life. 17 To lessen neurologic injury and improve neurodevelopmental outcomes in infants with moderate and severe HIE, therapeutic hypothermia beginning in the first 6 h of life has become standard clinical practice for infants with Clara's presentation. 28 Following a cooling period of 3 days, infants are slowly rewarmed and reevaluated with serial neurologic exams. A MRI study is then recommended in the first week 29 or two 30 of life to help clarify neurologic injury and neurodevelopmental prognosis, potentially aiding decision-making around withdrawal of life-supportive care. Neurologists are frequent consultants throughout hospitalization at many centers, 4 providing clinical assessments, seizure management, radiographic interpretation, NDI prognostication and descriptions of potential impacts that future disabilities may have for the child and family. 18 Given the interdisciplinary care and technological support that infants with significant HIE require, centers providing therapeutic hypothermia have been strongly encouraged to offer neuroimaging with MRI, aEEG and/or EEG monitoring, multi-disciplinary consultants and long-term neurodevelopmental follow-up capabilities. 31, 32 Clinical care approaches for neurologically at-risk VLBW infants Case: Today is day of life 7 for Carl, a 750-g male who was born at 24 weeks gestation following a pregnancy complicated by precipitous preterm labor and clinical chorioamnionitis. He is receiving care in a community level IIIa neonatal intensive care unit. Transient blood pressure instability in the first day of life necessitated a continuous dopamine infusion and mild fluid resuscitation. A blood culture was sent after birth and remained without growth. On day of life 4, a screening HUS was obtained which revealed a large Grade IV IVH on the left side and Grade II IVH on the right. Carl remains on a mechanical ventilator with increasing support requirements. The bedside nurse asks the neonatal provider during rounds if anyone has discussed withdrawal of life support with the family.
In contrast to term infants with significant HIE, acute brain injury in the majority of VLBW infants, including those with IVH and seizures, is a silent entity. 33, 34 Brain injury may be less clinically apparent in this population because its location (frequently subcortical) and because neuronal immaturity in preterm infants may make seizure activity less likely and less detectable. 35, 36 Seizures, when present, may be fully subclinical or manifest in subtle ways including mild dysautonomia and ocular fixation. 37, 38 In a recent study of infants born less than 30 weeks gestation, although nearly half of the infants had electrographic evidence of seizure activity within the first 72 h after birth, providers were only able to clinically detect the seizures in 7%. 39 A HUS within the first days of life has been the predominant clinical study used to detect brain injury in VLBW infants (for example, IVH, periventricular hemorrhagic infarction, hydrocephalus, periventricular leukomalacia) and predict neurologic outcomes for over 30 years. 29, 40 IVH is classified radiographically using a grading system established in the 1970s with severity based upon location, extent of hemorrhage and presence of hydrocephalus. 41 Some IVH subtypes, especially bilateral Grade IV IVH (which given its distinct pathophysiology and prognostic implications is more precisely classified as IVH with periventricular hemorrhagic infarction), have association with poor neurologic outcomes including substantial developmental delays and severe cerebral palsy. 42, 43 However, preterm infants with all grades of IVH have marked variability in neurodevelopmental outcomes 44, 45 and HUS studies, although frequently accurate in predictions of cerebral palsy, lack predictive abilities for cognitive impairments in this population. 46, 47 The historical affinity that neonatologists have to rely on HUS alone for neurologic diagnosis was confirmed by a recent survey of neonatal providers regarding their management of preterm infants with seizure activity. 7 In that study, neurologists were significantly more likely than neonatal practitioners to obtain MRI studies for diagnostic brain imaging of preterm infants with seizures. MRI studies have been shown to be beneficial for very preterm infants with seizures and IVH, providing therapeutic and prognostic information that is lacking with ultrasonography. [48] [49] [50] MRI studies can be safely obtained on VLBW infants even within the first 10 days of life. 51 MRI-compatible incubators, neonatal intensive care unit-based MRI scanners and protocols that avoid sedation have all aided in the safety of these studies at some centers. 52 It is notable that extending the benefit of a neurologically integrated approach to VLBW infants at one institution resulted in statistically significant reductions in reliance solely on ultrasonography for neurodiagnostic testing. 4 Seizure activity in VLBW infants is associated with both IVH and death. 39 Centers are increasingly publishing studies supporting the neurologic prognostic value of aEEG and conventional EEG studies for infants born very premature. 39, [53] [54] [55] [56] [57] Abnormal electrographic studies have predictive power for both motor and cognitive impairments in this population, 53,57 even as early as the first 12 to 24 h of life. 56 Additionally, aberrant electrocortical background activity has prognostic implications for neurodevelopmental outcome that exceeds the predictive abilities of HUS. 56 As in Carl's case, neurologic injury severity and prognosis for VLBW infants is frequently confounded by many clinical factors. Systemic inflammatory responses resulting from chorioamnionitis [58] [59] [60] and sepsis 61, 62 can have substantial detrimental effects on long-term neurodevelopment, including cognitive impairments 58, 61 and cerebral palsy. 59, 61, 62 There are also significant associations between sepsis and IVH in this population, elevating risks for substantial brain injury in affected infants. 58, 63 When concerns for future NDI arise in VLBW infants, a 'window of opportunity' may be available to offer parents a withdrawal of life-sustaining care while the infant remains ventilatordependent. 27 Historically, the presence of substantial IVH on HUS has been one principal consideration, along with other comorbid complications such as severe cardiovascular or pulmonary compromise, in decisions to offer care redirection to parents. 64 Studies describe divergent attitudes and practices among clinicians following notable neonatal IVH regarding the frequency with which they offer withholding and withdrawing treatment to families. [65] [66] [67] Rates of withdrawal of care for severe IVH at individual centers reflect this substantial variability. [68] [69] [70] Regional culture differences and parental thresholds for acceptance of possible disability may partially explain why decisions to discontinue life-supportive care vary markedly across sites. However, practice variability is reported regarding the frequency with which additional neurodiagnostic studies are obtained, namely MRI and aEEG/EEG studies, to clarify neurologic prognosis prior to withdrawing life-supportive care in this population. 66 Deregionalization of neonatal intensive care into smaller units with variable levels of consultative support and fewer annual admissions [71] [72] [73] may contribute to inconsistent subspecialty participation in the care of neurodevelopmentally at-risk VLBW infants. There are currently no standard therapeutic interventions available to premature infants with brain injury that would compel transfer to a center with neurology subspecialists, with the notable exception of those with progressive post-hemorrhagic hydrocephalus. This may engender deterministic attitudes in neonatal providers about the certainty of future NDI in premature infants after significant brain injury and impact perceptions of benefit for involving neurology specialists in this population's care.
Expanding neonatal neurologically integrated care The ethical implications of medical decision-making for infants like Clara and Carl with neurologic uncertainty has been discussed since the 1980s. 74 In one seminal paper, Rhoden 74 noted that 'infants born prematurely, or severely asphyxiated at birth, may die; they may live to develop normally; or they may survive but suffer from profound retardation or other severe impairments.' This outcome variability prompted questions of how best to make end-of-life decisions when predictive information was lacking. Rhoden suggested a clinical methodology utilizing an 'individualized prognostic approach' where 'doctors start treatment, gather as much information as possible, and then reassess.'
Defining a critical mass of information necessary to make informed clinical and prognostic decisions for infants with potential NDIs might be an increasing challenge for neonatal care providers, however. Technological advancements that allow better detection and potential clarification of neurologic injuries are continually emerging and finding proposed applications in neonatal care. 6 Novel diagnostic and therapeutic technologies that show benefit in reducing or predicting NDI may have ethical implications for providers, including an imperative to discuss their availability with parents and offer transfer to centers where they are offered. 75 To improve survival and neurodevelopmental outcomes, it has been proposed that infants with brain injury 'be cared for by a multi-disciplinary service consisting of neurologists, neonatologists and specialized nurses, and in a facility capable of providing specialized care'. 3 Neurologically integrated care approaches combine multiple neurodiagnostic modalities including brain imaging, EEG studies and neurobehavioral examinations that can achieve more reliable and accurate predictions of neurodevelopmental outcomes for neonatal patients of all ages. 76 These practices lead to better recognition of clinically silent neurologic injury and seizures through active cerebral monitoring 39 and provide superior abilities to monitor the impacts of intensive care on neurologic function in infants. 3 Although the risk and benefits of earlier detection and treatment of neurologic injury in these populations are not yet fully known, it is believed that this approach should ultimately lead to innovative care approaches that will improve outcomes for all infants with brain injury. 7 Increasing the involvement of neurologists and neurodevelopmental pediatricians in the care of term and premature infants with brain injury could provide many benefits to patients and families. These providers can offer longitudinal perspectives to families regarding outcomes, with knowledge of interventions that can maximize the developmental potential of infants with neurologic illnesses. They can also connect parents of at-risk infants to families whose children had similar medical histories resulting in significant disabilities to share experiences and help shape expectations. The establishment of collaborative relationships with other parents and providers who will support the family beyond the neonatal intensive care unit could influence medical decision-making in these clinical circumstances. 77, 78 Centers choosing to implement neurologically integrated care approaches could find an increased need to navigate conflicting opinions among multidisciplinary consultants with respect to personal interpretations of neurological prognosis and how best to counsel families about end-of-life decision-making. 79, 80 Although the impact of disagreements between providers on parents is not well understood, discussing discordant prognostic interpretations with families, if guided by established medical facts, could highlight a range of possible outcomes, reflect honest outcome ambiguity and be beneficial to family decision-making. 81 For infants with brain injury, Rhoden 74 believed 'when less is known about the outcome, there is a more compelling reason to continue treatment.' For term infants with asphyxial injury, current neurologically integrated care approaches incorporate aEEG studies, brain MRI and frequent serial examination of infants by neurology consultants throughout the first days and weeks of life to guide medical decision-making. However, for VLBW infants with potential neurologic injury, there are no current prognostic or neurodiagnostic standards of care beyond head ultrasonography. Given the predictive limitations of early HUS studies, decisions to withdraw life-supportive care focused principally on neurodevelopmental concerns for extremely premature infants without the elucidatory benefit of more advanced neurodiagnostic studies (for example, EEG, MRI), including skillful interpretations by neurology subspecialists, may lack enough prognostic information to support these decisions. 64, 76, 82 CONCLUSIONS Can variable neurodiagnostic approaches for infants of different gestational ages with potential neurologic injury such as Clara and Carl be substantiated? It has been argued that newborns as a group are treated differently from older children, with outcome uncertainties more frequently used to justify treatment withdrawals and less aggressive interventions. 83 We describe variations in clinical practice even among infants, with VLBW infants less likely to receive the benefit of neurodiagnostic and consultative support afforded by their full term counterparts.
Given that the technological and diagnostic limitations imposed by early gestational age and low birth weight resolve with time, differences in clinical approach among infants are problematic. 84 More frequent neurology subspecialty involvement in withdrawal of life support decision-making for term infants with neurologic injuries, compared with similar scenarios in extremely preterm infants, may reflect important differences in the comfort levels of neonatal providers making assessments of future neurologic impairment in these populations. More research is needed to describe the extent of these practice disparities, to understand the rationale, and to assess its impact on families and decisionmaking.
Technological advancements impacting neonatology require the availability of subspecialty providers for prognostic interpretations and skillful implementation. More widespread adoption of neonatal neurologically integrated critical care, guided by neonatal neurologists, should be considered to enhance the care of all infants with potential neurologic injury. Earlier neurologic consultation and participation in neonatal care should lead to a more comprehensive understanding of neurodevelopmental outcomes, encourage neuroprotective innovation and help ensure that the benefits of technological advancement be equitability distributed to all infants.
